Evaluation of an automated commercial ELISA method for calprotectin determination in pleural fluid

Articles in the same Issue

1. Frontmatter
2. Editorial
3. Biomarkers of acute kidney injury: a step forward
4. Reviews
5. Biomarkers of acute kidney injury: the pathway from discovery to clinical adoption
6. Prognostic value of glycated hemoglobin among patients with ST-segment elevation myocardial infarction: a systematic review and meta-analysis
7. Opinion Paper
8. Traceability in laboratory medicine: a global driver for accurate results for patient care
9. Point
10. To report or not to report: a proposal on how to deal with altered test results in hemolytic samples
11. Counterpoint
12. Reporting altered test results in hemolyzed samples: is the cure worse than the disease?
13. Genetics and Molecular Diagnostics
14. Early mixed hematopoietic chimerism detection by digital droplet PCR in patients undergoing gender-mismatched hematopoietic stem cell transplantation
15. Comparison of Abbott RealTime genotype II, GeneMatrix restriction fragment mass polymorphism and Sysmex HISCL HCV Gr assays for hepatitis C virus genotyping
16. General Clinical Chemistry and Laboratory Medicine
17. The relationship between vacuum and hemolysis during catheter blood collection: a retrospective analysis of six large cohorts
18. Evaluation of the Greiner Bio-One serum separator BCA Fast Clot tube
19. Implementation and application of moving average as continuous analytical quality control instrument demonstrated for 24 routine chemistry assays
20. Parathormone stability in hemodialyzed patients and healthy subjects: comparison on non-centrifuged EDTA and serum samples with second- and third-generation assays
21. Association between plasma proANP and hyperuricemia in Chinese Han women: a cross-sectional study
22. Activity of the liver enzyme ornithine carbamoyltransferase (OTC) in blood: LC-MS/MS assay for non-invasive diagnosis of ornithine carbamoyltransferase deficiency
23. Detecting paraprotein interference on a direct bilirubin assay by reviewing the photometric reaction data
24. Prediction of human iron bioavailability using rapid c-ELISAs for human plasma hepcidin
25. Reference Values and Biological Variations
26. Determination of glucose-6-phosphate dehydrogenase cut-off values in a Tunisian population
27. Plasma levels of endothelin-1 and renal function among young and healthy adults
28. Cancer Diagnostics
29. A new strategy for calculating the risk of ovarian malignancy algorithm (ROMA)
30. Laboratory characterization of leukemic cell procoagulants
31. Diabetes
32. Preparation, calibration and evaluation of the First International Standard for human C-peptide
33. Hb variants in Korea: effect on HbA_1c using five routine methods
34. Letters to the Editor
35. Pseudohyperkalemia in capillary whole-blood samples – an occasional error or a significant problem in a pediatric hospital?
36. Elevation of creatine kinase is linked to disease severity and predicts fatal outcomes in H7N9 infection
37. Analytical evaluation of point-of-care procalcitonin (PCT) and clinical performances in an unselected population as compared with central lab PCT assay
38. Evaluation of an automated commercial ELISA method for calprotectin determination in pleural fluid
39. The unfinished story of interference in thyroid hormones with Roche immunoassays: when prewashing procedures matter
40. Effects of apixaban on prothrombin time, activated partial thromboplastin time and anti-Xa assays: a European survey
41. Evaluation of a chemiluminescent immunoassay for urinary aldosterone on the DiaSorin LIAISON automated platform against RIA and LC-MS/MS
42. Complex considerations when tendering for HbA_1c analysers